{
  "id": 12190357,
  "title": "Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business",
  "url": "https://urgent.news/2026/10/05/shionogi-to-buy-us-based-intrabio-for-2bn-to-expand-rare-disease-drug",
  "topic": "world",
  "section": "World",
  "published": "2026-10-05T14:52:18.000Z",
  "source": {
    "name": "Nikkei Asia",
    "slug": "nikkei-asia",
    "url": "https://asia.nikkei.com/business/pharmaceuticals/shionogi-to-buy-us-based-intrabio-for-2bn-to-expand-rare-disease-drug-business"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}